Professor Andrew Biankin
Head, Pancreatic Cancer Research, Cancer Program, Garvan Institute of Medical Research; Consultant Gastrointestinal Surgeon, Sydney Upper GI Unit, Sydney South West Area Health Service; Chairman, NSW Pancreatic Cancer Network; Professor, Conjoint Appointee University of NSW.
Email: a.biankin 'at' garvan.org.au
Research Group: Pancreatic Cancer
Education
2004 Postdoctoral Fellow Johns Hopkins Medical Institutions
2003 Ph. D. University of NSW
1999 F.R.A.C.S. Royal Australasian College of Surgeons
1992 M.B., B.S. (Hons) University of NSW
1988 B. Med. Sc. University of NSW
Awards and Honours
2008 Hirshberg Award for Pancreatic Cancer, American Pancreatic Association
2008 Cancer Institute NSW Career Development and Support Fellowship
2007 Cancer Institute NSW Outstanding Fellow Award
2005 Cure Cancer Australia Young Investigator of the Year
2005 Travel Award, Surgical Research Society of Australia
2004 Excellence in Translational Research Award, Johns Hopkins University
2003 Thesis Prize, Garvan Institute of Medical Research
2003 - 2006 Neil Hamilton Fairley Postdoctoral Fellowship, National Health & Medical Research Council
2003 Travelling Fellowship, Royal Australasian College of Surgeons
2002 Travelling Fellowship, St Vincent's Clinic Foundation
2002 Warren Fellowship (International Hepato-Pancreato-Biliary Association)
2001 Annual St Vincent's Campus Research Symposium Award for excellence in research
2001 Young Investigator Award, Johns-Hopkins Medical Institutions, Baltimore, Maryland, USA/The Lustgarten Foundation for Pancreatic Cancer Research
2001 Travelling Fellowship, International Surgical Society
2000 Annual St Vincent's Campus Research Symposium Award for excellence in poster presentation.
1999 - 2002 National Health & Medical Research Council, Medical Postgraduate Scholarship
1999 - 2002 Sir Roy McCaughey Fellowship, Royal Australasian College of Surgeons
1999 Di Boyd Cancer Research Award, St Vincent's Clinic Foundation
Publications
Biankin AV, Kench JG, Colvin EK, Segara D, Scarlett CJ, Nguyen NQ, Chang DK, Skalicky DA, Morey AL, Lee CS, O’Toole SA, Pinese M, Kuo SCL, Susanto JM, Cosman PH, Lindeman GJ, Visvader JE, Merrett ND, Musgrove EA, Henshall SM, Sutherland RL. (2009) Expression of S100A2 calcium-binding protein Predicts Response to Pancreatectomy for Pancreatic Cancer. Gastroenterolgy 2009; 137:558-68
Prasad N, Biankin AV, Fukushima N et al. Gene expression profiles in pancreatic Intraepithelial neoplasia reflect the effects of hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res 2005; 65(5):1619-1626.
Hansel DE, Maitra A, Lin JW et al. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater. J Clin Oncol 2005; 23(9):1811-1818.
Segara D, Biankin AV, Kench JG et al. Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia. Clin Cancer Res 2005; 11(9):3587-3596.
Hruban RH, Adsay NV, Albores-Saavedra J et al. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res 2006; 66(1):95-106.
Henshall SM, Horvath LG, Quinn DI et al. Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy. J Natl Cancer Inst 2006; 98(19):1420-1424.
Pasca di Magliano M, Biankin AV, Heiser PW et al. Common activation of canonical Wnt signaling in pancreatic adenocarcinoma. PLoS One 2007; 2(11):e1155.
Heiser PW, Cano DA, Kim GE et al. Stabilization of _-catenin induces pancreas tumor formation. Gastroenterology 2008; 135(4):1288-1300.
Leong RWL, Nguyen N, Meredith CG et al. In vivo confocal endomicroscopy in the diagnosis and evaluation of celiac disease. Gastroenterology 2008; 135(6):1870-1876.
Chang DK, Johns AL, Merrett ND et al. Margin clearance and outcome in resected pancreatic cancer. J Clin Oncol 2009; 27(17):2855-2862.
